KUALA LUMPUR, Feb 3 (Bernama) -- Zenas BioPharma Inc, a clinical-stage global biopharmaceutical company, has announced its management team will present in a fireside chat at the Guggenheim SMID Cap Biotech Conference on Feb 5.
According to a statement, the presentation will be available via a live webcast, and an archived replay can be accessed under the "Events and Presentations" section of the Investor & Media Relations page on the Zenas BioPharma website.
Zenas is committed to becoming a leader in the development and commercialisation of transformative immunology-based therapies, aiming to improve the lives of those facing autoimmune and rare diseases.
-- BERNAMA
